| 产品名称： | Vaccinia virus |
|---|---|
| 商品货号： | TS178745 |
| Classification： | Poxviridae, Orthopoxvirus |
| Agent： | Vaccinia virus |
| Strain： | vP-8 recombinant Vaccinia virus |
| Applications： | expression vector |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | -70°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Recombinant vaccinia containing pBR322 insert at BamH1 site of HindIII F-fragment of VR-2031 (VTK-79). This is a recombinant vaccinia virus containing a pBR322 insert at the BamHI site of the HindIII F-fragment of VTK-79 (ATCC VR-2031). Plasmids can be introduced into this mutant by in vivo recombination. |
| Effect on Host： | Cytopathic effects in tissue culture |
| Name of Depositor： | New York State Department of Health |
| U.S. Patent： | |
| U.S. Patent Number： | |
| References： | Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Vaccinia virus |
|---|---|
| 商品货号： | TS178745 |
| Classification： | Poxviridae, Orthopoxvirus |
| Agent： | Vaccinia virus |
| Strain： | vP-8 recombinant Vaccinia virus |
| Applications： | expression vector |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | -70°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Recombinant vaccinia containing pBR322 insert at BamH1 site of HindIII F-fragment of VR-2031 (VTK-79). This is a recombinant vaccinia virus containing a pBR322 insert at the BamHI site of the HindIII F-fragment of VTK-79 (ATCC VR-2031). Plasmids can be introduced into this mutant by in vivo recombination. |
| Effect on Host： | Cytopathic effects in tissue culture |
| Name of Depositor： | New York State Department of Health |
| U.S. Patent： | |
| U.S. Patent Number： | |
| References： | Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986 Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988 Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520 |
